AIM2 and metabolic dysfunction-associated steatohepatitis: Some reports have shown that mitophagy restrains the inflammasome-proinflammatory cytokine axis, including the NLRP3-IL1β axis and the AIM2-IL-18 axis, via damaged mitochondrial clearance and reduced ROS production, thus limiting inflammation during NASH 29, 45, 46.